Photo from Guru P. Sonpavde/X
Apr 11, 2024, 11:56
Guru P. Sonpavde: AACR – Many promising options for Phase I clinical trials
Guru P. Sonpavde, GU Oncology Director at Advent Health Cancer Institute, shared on X/Twitter:
“AACR24 AACR – Many promising options for Phase I clinical trials – searching for the best trials for our rapidly growing program AdventHealth Central Florida cancer Institute, Orlando, Florida– eager to explore collaborations!”
Source: Guru P. Sonpavde/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19
Dec 21, 2024, 19:18
Dec 21, 2024, 18:59
Dec 21, 2024, 18:57
Dec 21, 2024, 18:54